Sunrest Lifescience Share Price

  • 49.00-0.21 (-0.41%)
  • Volume: 3,200
NSE
  • Closed
  • Last Updated On:
Loading...
Sunrest Lifescience Share Price
  • 49.00-0.21 (-0.41%)
  • Volume: 3,200
Advertisment

Sunrest Lifescience share price insights

  • Company's annual revenue growth of 12.34% outperformed its 3 year CAGR of 7.1%. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 14.56% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Sunrest Lifescience Ltd. share price moved down by -0.41% from its previous close of Rs 49.20. Sunrest Lifescience Ltd. stock last traded price is 49.00

    Share PriceValue
    Today/Current/Last49.00
    Previous Day49.20-

InsightsSunrest Lifescience

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    0.00
    EPS - TTM
    (₹)
    0.00
    MCap
    (₹ Cr.)
    21.03
    Sectoral MCap Rank
    643
    PB Ratio
    (x)
    0.98
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    48.25
    52W H/L
    (₹)
    75.00 / 44.60

    Sunrest Lifescience Share Price Returns

    1 Day-0.41%
    1 WeekN.A.
    1 MonthN.A.
    3 MonthsN.A.
    1 YearN.A.
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Sunrest Lifescience belongs to analysts' top-rated companies list?

    View Stock Screeners

    Sunrest Lifescience News & Analysis

    We don't have any recent updates for this stock. We suggest you to explore other sections.

    Sunrest Lifescience Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Sunrest Lifescience Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Sunrest Lifescience Financials

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 12.34% outperformed its 3 year CAGR of 7.1%. (Source: Standalone Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 14.56% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Annual FY 2025
      Total Revenue33.42
      Total Revenue Growth (%)-
      Total Expenses30.79
      Total Expenses Growth (%)-
      Profit after Tax (PAT)2.01
      PAT Growth (%)-
      Operating Profit Margin (%)8.76
      Net Profit Margin (%)6.00
      Basic EPS (₹)4.67
      Annual FY 2025 FY 2024 FY 2023 FY 2022
      Total Revenue33.1229.4824.6726.91
      Total Revenue Growth (%)12.3419.51-8.3258.77
      Total Expenses30.5128.8921.9325.86
      Total Expenses Growth (%)5.6231.76-15.2154.61
      Profit after Tax (PAT)2.000.232.040.78
      PAT Growth (%)786.04-88.95162.91369.55
      Operating Profit Margin (%)8.782.0111.133.90
      Net Profit Margin (%)6.030.768.292.89
      Basic EPS (₹)4.660.686.812.59

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2025
      Total Assets58.65
      Total Assets Growth (%)-
      Total Liabilities37.02
      Total Liabilities Growth (%)-
      Total Equity21.63
      Total Equity Growth (%)-
      Current Ratio (x)1.73
      Total Debt to Equity (x)0.74
      Contingent Liabilities0.00
      Annual FY 2025 FY 2024 FY 2023 FY 2022
      Total Assets35.1625.1616.7113.02
      Total Assets Growth (%)39.7550.5728.3437.34
      Total Liabilities18.9710.9713.6011.95
      Total Liabilities Growth (%)72.93-19.3413.8130.03
      Total Equity16.1914.193.121.07
      Total Equity Growth (%)14.09354.81191.59268.97
      Current Ratio (x)1.943.311.411.42
      Total Debt to Equity (x)0.380.430.693.02
      Contingent Liabilities0.000.020.02-

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Cash from Operations vs PAT

        Operating cash flow of Rs 1.43 cr is 0.71 times compared to the reported net profit of Rs 2.01 cr. (Source: Consolidated Financials)
      Annual FY 2025
      Net Cash flow from Operating Activities1.43
      Net Cash used in Investing Activities-1.15
      Net Cash flow from Financing Activities-0.33
      Net Cash Flow-0.04
      Closing Cash & Cash Equivalent0.25
      Closing Cash & Cash Equivalent Growth (%)-
      Total Debt/ CFO (x)8.44
      Annual FY 2025 FY 2024 FY 2023 FY 2022
      Net Cash flow from Operating Activities1.43-14.801.15-0.45
      Net Cash used in Investing Activities-1.14-0.01-0.03-0.36
      Net Cash flow from Financing Activities-0.3014.64-1.150.91
      Net Cash Flow-0.01-0.16-0.030.11
      Closing Cash & Cash Equivalent0.280.290.450.48
      Closing Cash & Cash Equivalent Growth (%)-3.63-35.65-6.2728.65
      Total Debt/ CFO (x)4.32-0.421.86-7.22

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025
      Return on Equity (%)12.29
      Return on Capital Employed (%)10.57
      Return on Assets (%)3.41
      Interest Coverage Ratio (x)9.89
      Asset Turnover Ratio (x)-
      Price to Earnings (x)11.51
      Price to Book (x)1.41
      EV/EBITDA (x)12.80
      EBITDA Margin (%)9.05
      Annual FY 2025 FY 2024 FY 2023 FY 2022
      Return on Equity (%)12.351.5965.5872.49
      Return on Capital Employed (%)14.123.3553.6725.22
      Return on Assets (%)5.680.8912.225.96
      Interest Coverage Ratio (x)9.940.000.000.00
      Asset Turnover Ratio (x)1.101.411.662.39
      Price to Earnings (x)11.55117.65--
      Price to Book (x)1.431.85--
      EV/EBITDA (x)9.6546.47--
      EBITDA Margin (%)9.052.3411.664.12

    Financial InsightsSunrest Lifescience

    • Income (P&L)
    • Cash Flow
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 12.34% outperformed its 3 year CAGR of 7.1%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 14.56% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Cash from Operations vs PAT

        Operating cash flow of Rs 1.43 cr is 0.71 times compared to the reported net profit of Rs 2.01 cr. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Sunrest Lifescience Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Sunrest Lifescience Peer Comparison

      • There’s no suggested peer for this stock.
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Sunrest Lifescience0.000.9712.2910.573.417.418.766.014.671.730.748.44
      Add More stocks of your interest to compare.
      Annual Ratios (%)

      Choose from Peers

        Choose from Stocks

        Peers InsightsSunrest Lifescience

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Sunrest Lifescience Shareholding Pattern

          • Loading...
            Showing Sunrest Lifescience Shareholding as on Jun 2025
            CategoryJun 2025Dec 2024Sep 2024Mar 2024
            Promoters69.9169.9169.9169.91
            Pledge0.000.000.000.00
            FII0.000.000.000.00
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others30.0930.0930.0930.09
          • Showing Shareholding as on Jun 2025
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters30,00,00069.91 %0.00
            Pledge00.00 %0.00
            Others12,91,20030.09 %0.00

          Sunrest Lifescience MF Ownership

          MF Ownership details are not available.

          Sunrest Lifescience Corporate Actions

          • Meeting DateAnnounced onPurposeDetails
            May 30, 2025May 28, 2025Board MeetingAudited Results
            May 27, 2025May 14, 2025Board MeetingAudited Results
            Nov 14, 2024Nov 07, 2024Board MeetingQuarterly Results
            Sep 28, 2024Sep 04, 2024AGMBook closure from Sep 21, 2024 to Sep 28, 2024
            May 27, 2024May 18, 2024Board MeetingAudited Results
          • Dividend announcements are not available.

          • No other corporate actions details are available.

          About Sunrest Lifescience

          • Executives

          • Auditors

          • JS

            Juhi Sawajani

            Chairman(NonExe.&Ind.Director)
            NY

            Nikhilkumar Yashvntlal Thakkar

            Managing Director
            AS

            Amitbhai Shambhulal Thakkar

            Whole Time Director
            BK

            Bhagyesh Kiritbhai Parekh

            Non Executive Director
            Show More
          • Madhusudan C Mashruwala & Co.

          FAQs about Sunrest Lifescience share

          • 1. What's Sunrest Lifescience share price today and what are Sunrest Lifescience share returns ?
            Sunrest Lifescience share price is Rs 49.00 as on 08 Sep, 2025, 03:31 PM IST.
          • 2. What is the PE & PB ratio of Sunrest Lifescience?
            The PE ratio of Sunrest Lifescience stands at null, while the PB ratio is 0.98.
          • 3. What is Sunrest Lifescience's 52 week high / low?
            In last 52 weeks Sunrest Lifescience share had a high price of Rs 75.00 and low price of Rs 44.60
          • 4. What is the market cap of Sunrest Lifescience?
            Market Capitalization of Sunrest Lifescience stock is Rs 21.03 Cr.

          Trending in Markets

          Top Gainers As on 03:59 PM | 08 Sep 2025

          Suven Pharma 1,012.95
          90.06 (9.76%)
          Guj Mineral Dev.539.15
          30.15 (5.93%)
          Bharat Forge1,202.80
          66.10 (5.82%)
          Ashok Leyland137.29
          6.52 (4.99%)
          JP Power20.02
          0.95 (4.99%)

          Top Losers As on 03:57 PM | 08 Sep 2025

          Amber Enterprises7,473.00
          -320.50 (-4.12%)
          EID Parry1,067.30
          -45.50 (-4.09%)
          Trent5,315.50
          -213.00 (-3.86%)
          Godfrey Philips10,657.00
          -416.00 (-3.76%)
          Coromandel Int.2,185.20
          -72.71 (-3.22%)

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          The Economic Times